Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01188889
Title RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

chronic myeloid leukemia

Therapies

Everolimus + Imatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.